Lavico

Inabata America Corporation provides a global perspective to new business opportunities as a wholly owned subsidiary of Inabata & Co, one of Japan's leading niche integrated trading and investment companies. Headquartered in New York City's Rockefeller Center since 1978, Inabata America Corporation also has facilities in Chicago, El Paso,Texas, Juarez Mexico, the Silicon Valley, Los Angeles and San Diego. Inabata America Corporation provides solutions and services for information technology, electronics, chemicals, plastics and food enterprises throughout the world. For more than a century, Inabata's specialized functions have satisfied a variety of client requirements through business planning, marketing, manufacturing and supply chain management. Inabata America Corporation s facility in New York employs nearly 40 people.

Anavex Life Sciences Corp. is a biopharmaceutical company based in New York, NY, dedicated to developing novel small molecule treatments for challenging central nervous system diseases such as Alzheimer's disease, Parkinson's disease, and rare conditions like Rett syndrome. Through its proprietary SIGMACEPTOR platform, the company targets the Sigma-1 receptor (SIGMAR1) to potentially enhance the body's own defenses against neurodegeneration. With an emphasis on precision medicine, Anavex focuses on addressing the needs of patients and caregivers affected by neurodegenerative and neurodevelopmental disorders. Their investigational drug, ANAVEX 2-73 (blarcamesine), aims to improve autophagy and restore neural cell homeostasis, with ongoing efforts to engage with the community and ensure access to new treatment paradigms. Generated from the website